交易 Dechra Pharmaceuticals PLC - DPH CFD
加入收藏夹- 概括
- 曆史數據
- 活動
- 收入報表
- 資産負債表
- 現金流
- 所有權
交易條件
价差 | 0.20 | ||||||||
多头隔夜费
多头隔夜费
前往平台 | -0.025261% | ||||||||
空头隔夜费
空头隔夜费
前往平台 | 0.003343% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | GBP | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United Kingdom of Great Britain and Northern Ireland | ||||||||
交易费 | 0% |
*Information provided by Capital.com
Dechra Pharmaceuticals PLC ESG Risk Ratings
High Medium Low Negligible
“B”分數表示相對 ESG 表現良好,公開報告重要 ESG 數據的透明度高於平均水平。
- 上週
- 上個月
- 去年
- 過去兩年
- 最大
- 每日
- 每週
- 每月
日期 | 關閉 | 更改 | 變化 (%) | 打開 | 高 | 低 |
---|---|---|---|---|---|---|
Dec 7, 2023 | 38.22 | 0.04 | 0.10% | 38.18 | 38.26 | 38.18 |
Dec 6, 2023 | 38.26 | 0.54 | 1.43% | 37.72 | 38.28 | 37.72 |
Dec 5, 2023 | 38.22 | 0.00 | 0.00% | 38.22 | 38.24 | 38.08 |
Dec 4, 2023 | 38.22 | 0.04 | 0.10% | 38.18 | 38.22 | 38.02 |
Dec 1, 2023 | 38.18 | 0.20 | 0.53% | 37.98 | 38.22 | 37.96 |
Nov 30, 2023 | 38.16 | 0.02 | 0.05% | 38.14 | 38.18 | 37.92 |
Nov 29, 2023 | 38.16 | 0.04 | 0.10% | 38.12 | 38.20 | 38.12 |
Nov 28, 2023 | 38.16 | 0.08 | 0.21% | 38.08 | 38.16 | 38.08 |
Nov 27, 2023 | 38.16 | 0.26 | 0.69% | 37.90 | 38.16 | 37.90 |
Nov 24, 2023 | 38.14 | 0.04 | 0.10% | 38.10 | 38.14 | 38.10 |
Nov 23, 2023 | 38.12 | 0.02 | 0.05% | 38.10 | 38.14 | 38.10 |
Nov 22, 2023 | 38.12 | 0.34 | 0.90% | 37.78 | 38.12 | 37.78 |
Nov 21, 2023 | 38.10 | 0.02 | 0.05% | 38.08 | 38.10 | 38.04 |
Nov 20, 2023 | 38.10 | 0.00 | 0.00% | 38.10 | 38.16 | 38.06 |
Nov 17, 2023 | 38.14 | 0.44 | 1.17% | 37.70 | 38.24 | 37.50 |
Nov 16, 2023 | 37.70 | -0.02 | -0.05% | 37.72 | 37.80 | 37.66 |
Nov 15, 2023 | 37.54 | -0.20 | -0.53% | 37.74 | 37.80 | 37.52 |
Nov 14, 2023 | 37.76 | 0.06 | 0.16% | 37.70 | 37.82 | 37.56 |
Nov 13, 2023 | 37.76 | 0.42 | 1.12% | 37.34 | 37.78 | 37.34 |
Nov 10, 2023 | 37.70 | -0.04 | -0.11% | 37.74 | 37.78 | 37.64 |
Dechra Pharmaceuticals PLC Events
时间(协调世界时) (UTC) | 国家 | 事件 |
---|---|---|
Wednesday, December 13, 2023 | ||
时间(协调世界时) (UTC) 11:00 | 国家 GB
| 事件 Dechra Pharmaceuticals PLC Annual Shareholders Meeting Dechra Pharmaceuticals PLC Annual Shareholders MeetingForecast(预报) -上一页 - |
Tuesday, February 27, 2024 | ||
时间(协调世界时) (UTC) 10:59 | 国家 GB
| 事件 Half Year 2024 Dechra Pharmaceuticals PLC Earnings Release Half Year 2024 Dechra Pharmaceuticals PLC Earnings ReleaseForecast(预报) -上一页 - |
- 年度
- 每季度
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
總收入 | 761.5 | 681.8 | 608 | 515.1 | 481.8 |
收入 | 761.5 | 681.8 | 608 | 515.1 | 481.8 |
收入成本,共計 | 331.9 | 296.5 | 262.1 | 223.5 | 203.6 |
毛利 | 429.6 | 385.3 | 345.9 | 291.6 | 278.2 |
總營業費用 | 776.6 | 599.8 | 521.2 | 465.4 | 443.8 |
銷售/一般/行政費用,總計 | 207 | 178.6 | 151.3 | 134.9 | 125.7 |
研究與開發 | 57.5 | 32.4 | 32.4 | 28.4 | 25.1 |
Depreciation / Amortization | 140.2 | 72.8 | 75.2 | 69.6 | 76.8 |
異常費用(收入) | 40 | 19.5 | 0.2 | 9 | 12.6 |
營業收入 | -15.1 | 82 | 86.8 | 49.7 | 38 |
利息收入(費用),非經營淨值 | -21 | -4.4 | -12.8 | -8.8 | -10.2 |
其他,淨值 | 0 | ||||
稅前淨收入 | -36.1 | 77.6 | 74 | 40.9 | 27.8 |
稅後淨收入 | -27.9 | 58.2 | 55.5 | 33.9 | 20.9 |
少數股東權益 | 0 | ||||
未計算非常項目前的淨收益 | -27.9 | 58.2 | 55.5 | 33.9 | 20.9 |
淨收入 | -27.9 | 58.2 | 55.5 | 33.9 | 30.9 |
普通股股東可獲收益 (不含非經常性項目) | -27.9 | 58.2 | 55.5 | 33.9 | 20.9 |
普通股股東可獲收益 (含非經常性項目) | -27.9 | 58.2 | 55.5 | 33.9 | 30.9 |
攤薄調整 | 0 | ||||
攤薄淨收入 | -27.9 | 58.2 | 55.5 | 33.9 | 30.9 |
攤薄後加權平均股 | 113.477 | 108.987 | 108.751 | 103.482 | 102.762 |
扣除特別項目的每股攤薄盈利 | -0.24587 | 0.53401 | 0.51034 | 0.32759 | 0.20338 |
Dividends per Share - Common Stock Primary Issue | 0.4489 | 0.405 | 0.3429 | 0.316 | |
每股正常攤薄盈利 | 0.57545 | 0.95974 | 0.72643 | 0.58561 | 0.59847 |
非常規項目總計 | 10 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
總收入 | 384.1 | 377.4 | 349.4 | 332.4 | 308.2 |
收入 | 384.1 | 377.4 | 349.4 | 332.4 | 308.2 |
收入成本,共計 | 174 | 158.1 | 153.3 | 143.2 | 133 |
毛利 | 210.1 | 219.3 | 196.1 | 189.2 | 175.2 |
總營業費用 | 436.8 | 339.8 | 324.2 | 275.6 | 262.9 |
銷售/一般/行政費用,總計 | 104.5 | 102.5 | 96.8 | 81.8 | 76.5 |
研究與開發 | 31 | 26.5 | 18.9 | 13.5 | 17.3 |
Depreciation / Amortization | 32.5 | 38.6 | 37.4 | 35.4 | 36.9 |
異常費用(收入) | 94.8 | 14.1 | 17.8 | 1.7 | -0.8 |
營業收入 | -52.7 | 37.6 | 25.2 | 56.8 | 45.3 |
利息收入(費用),非經營淨值 | -13.1 | -7.9 | -1 | -3.4 | -6.7 |
其他,淨值 | |||||
稅前淨收入 | -65.8 | 29.7 | 24.2 | 53.4 | 38.6 |
稅後淨收入 | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
未計算非常項目前的淨收益 | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
淨收入 | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
普通股股東可獲收益 (不含非經常性項目) | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
普通股股東可獲收益 (含非經常性項目) | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
攤薄調整 | 0 | ||||
攤薄淨收入 | -50.5 | 22.6 | 17.5 | 40.7 | 32.2 |
攤薄後加權平均股 | 113.858 | 113.824 | 109.083 | 108.892 | 108.803 |
扣除特別項目的每股攤薄盈利 | -0.44353 | 0.19855 | 0.16043 | 0.37376 | 0.29595 |
Dividends per Share - Common Stock Primary Issue | 0.125 | 0.3289 | 0.12 | 0.2939 | |
每股正常攤薄盈利 | 0.75006 | 0.42873 | 0.49595 | 0.46376 | 0.46598 |
- 年度
- 每季度
2023 | 2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|---|
流動資産總額 | 467.9 | 444.4 | 392.2 | 448.9 | 291.5 |
現金和短期投資 | 74.4 | 120.9 | 118.4 | 227.4 | 80.3 |
现金 | 74.4 | 120.9 | 118.4 | 227.4 | 80.3 |
短期投資 | |||||
應收賬款總額,淨額 | 169.6 | 142.1 | 119.2 | 97.3 | 103.8 |
應收賬款 - 貿易,淨額 | 144.2 | 122.1 | 88.2 | 79.4 | 91.1 |
總庫存 | 217.3 | 175.7 | 149.5 | 120.8 | 103.5 |
預付的費用 | 6.6 | 5.7 | 5.1 | 3.4 | 3.9 |
總資産 | 1569.4 | 1293.3 | 1214.1 | 1237.6 | 1041.5 |
物業/廠房/設備,總計 - 淨額 | 159.3 | 100.3 | 87 | 76.4 | 58.4 |
物業/廠房/設備,總計 - 總額 | 224.7 | 161.9 | 140 | 127.8 | 100.8 |
累計折舊,總計 | -65.4 | -61.6 | -53 | -51.4 | -42.4 |
商譽,淨額 | 334.5 | 245.4 | 236.1 | 253.8 | 245.7 |
無形資産,淨額 | 587.9 | 485.1 | 479.7 | 438.4 | 434.9 |
長期投資 | 14.9 | 15.8 | 17.1 | 17.4 | 10.1 |
其他長期資産,總計 | 4.9 | 2.3 | 2 | 2.7 | 0.9 |
流動負債總額 | 164 | 158.7 | 155.8 | 137.3 | 118.1 |
應付賬款 | 43.4 | 46 | 35.2 | 34.6 | 31.9 |
預提費用 | 98.8 | 87.7 | 74.4 | 60.5 | 61.7 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 3.9 | 3.3 | 3.1 | 4.6 | 1.2 |
其他流動負債,總計 | 17.9 | 21.7 | 43.1 | 37.6 | 23.3 |
負債總額 | 814.2 | 626.5 | 581.2 | 600.1 | 532.4 |
長期債務總額 | 500.6 | 325.8 | 317.6 | 353.1 | 309.6 |
長期債務 | 487.6 | 313.7 | 304.8 | 341.3 | 309.6 |
資本租賃義務 | 13 | 12.1 | 12.8 | 11.8 | 0 |
遞延所得稅 | 76.3 | 35.8 | 48.8 | 62.6 | 74.5 |
少數股權 | |||||
其他負債,總計 | 73.3 | 106.2 | 59 | 47.1 | 30.2 |
總權益 | 755.2 | 666.8 | 632.9 | 637.5 | 509.1 |
普通股 | 1.1 | 1.1 | 1.1 | 1.1 | 1 |
額外實收資本 | 596 | 413.9 | 411.6 | 409.3 | 277.9 |
留存收益(累計赤字) | 171 | 248.4 | 232.1 | 210.8 | 208.6 |
Treasury Stock - Common | -0.2 | ||||
其他權益,總計 | -12.7 | 3.4 | -11.9 | 16.3 | 21.6 |
總負債和股東權益 | 1569.4 | 1293.3 | 1214.1 | 1237.6 | 1041.5 |
已發行普通股總數 | 113.888 | 108.393 | 108.215 | 108.011 | 102.652 |
Jun 2023 | Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | |
---|---|---|---|---|---|
流動資産總額 | 467.9 | 459.3 | 444.4 | 376 | 392.2 |
現金和短期投資 | 74.4 | 87.9 | 120.9 | 123.7 | 118.4 |
現金等價物 | |||||
應收賬款總額,淨額 | 176.2 | 147.6 | 147.8 | 99.9 | 124.3 |
應收賬款 - 貿易,淨額 | 161.9 | 125.9 | 136.8 | 85.6 | 106.7 |
總庫存 | 217.3 | 223.8 | 175.7 | 149.4 | 149.5 |
總資産 | 1569.4 | 1744.3 | 1293.3 | 1177.7 | 1214.1 |
物業/廠房/設備,總計 - 淨額 | 159.3 | 155.3 | 100.3 | 92.3 | 87 |
無形資産,淨額 | 922.4 | 1111.2 | 730.5 | 689.4 | 715.8 |
長期投資 | 14.9 | 15.4 | 15.8 | 17.7 | 17.1 |
其他長期資産,總計 | 4.9 | 3.1 | 2.3 | 2.3 | 2 |
流動負債總額 | 164 | 168.4 | 158.7 | 129.2 | 155.8 |
Payable/Accrued | 144.5 | 139.3 | 136.8 | 99.9 | 113.5 |
應付票據/短期債務 | 0 | 0 | 0 | 0 | 0 |
長期債務的當前部分/資本租賃 | 3.9 | 3.2 | 3.3 | 3.1 | 3.1 |
其他流動負債,總計 | 15.6 | 25.9 | 18.6 | 26.2 | 39.2 |
負債總額 | 814.2 | 902.6 | 626.5 | 538.6 | 581.2 |
長期債務總額 | 500.6 | 508 | 325.8 | 313.7 | 315.5 |
長期債務 | 500.6 | 508 | 325.8 | 313.7 | 315.5 |
遞延所得稅 | 76.3 | 124.8 | 35.8 | 43.4 | 48.8 |
其他負債,總計 | 73.3 | 101.4 | 106.2 | 52.3 | 61.1 |
總權益 | 755.2 | 841.7 | 666.8 | 639.1 | 632.9 |
普通股 | 1.1 | 1.1 | 1.1 | 1.1 | 1.1 |
額外實收資本 | 596 | 594.7 | 413.9 | 413.3 | 411.6 |
留存收益(累計赤字) | 171 | 235.4 | 248.4 | 242.3 | 232.1 |
Treasury Stock - Common | -0.2 | ||||
其他權益,總計 | -12.7 | 10.5 | 3.4 | -17.6 | -11.9 |
總負債和股東權益 | 1569.4 | 1744.3 | 1293.3 | 1177.7 | 1214.1 |
已發行普通股總數 | 113.888 | 113.837 | 108.393 | 108.365 | 108.215 |
现金 | 74.4 | 87.9 | 120.9 | 123.7 | 118.4 |
其他流動資産,總計 | 0 | 3 |
- 年度
- 每季度
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
净收入/起跑线 | 95.5 | 84 | 52.2 | 39 | 34.1 |
经营活动产生的现金 | 122.9 | 89.1 | 106.4 | 81.8 | 64 |
经营活动产生的现金 | 11.1 | 11 | 9.9 | 5.7 | 4.8 |
Amortization | 78 | 4.5 | 4.3 | 4.1 | 2.6 |
非现金物品 | 6.5 | 77.7 | 69.8 | 79 | 63.1 |
Cash Taxes Paid | 32.9 | 43.9 | 12.9 | 17.3 | 11.5 |
已付现金利息 | 7.5 | 8.2 | 8.2 | 9.2 | 5.7 |
营运资金的变化 | -68.2 | -88.1 | -29.8 | -46 | -40.6 |
投资活动产生的现金 | -78.3 | -136.1 | -81.5 | -61.9 | -241.7 |
资本支出 | -77.6 | -134.8 | -49.2 | -22.5 | -12.6 |
其他投资现金流量项目,总计 | -0.7 | -1.3 | -32.3 | -39.4 | -229.1 |
融资活动产生的现金 | -46.1 | -55.1 | 118.9 | -20.1 | 193.8 |
融资现金流项目 | 0 | -1.7 | -0.2 | -3.9 | |
Total Cash Dividends Paid | -44.8 | -37.9 | -33.3 | -28.4 | -21.8 |
股票的发行(报废),净额 | 2.3 | 2.3 | 131.5 | 1.2 | 103.3 |
债务的发行(退还),净额 | -3.6 | -19.5 | 22.4 | 7.3 | 116.2 |
外汇效应 | 4 | -6.9 | 3.3 | 0.8 | 2.4 |
现金净变化 | 2.5 | -109 | 147.1 | 0.6 | 18.5 |
Dec 2022 | Jun 2022 | Dec 2021 | Jun 2021 | Dec 2020 | |
---|---|---|---|---|---|
Net income/Starting Line | 44.6 | 95.5 | 57.4 | 84 | 40.3 |
Cash From Operating Activities | 51.5 | 122.9 | 88.1 | 89.1 | 58.1 |
Cash From Operating Activities | 6.2 | 11.1 | 5.2 | 11 | 5.3 |
Amortization | 39.3 | 78 | 37.6 | 4.5 | 2.1 |
Non-Cash Items | 3.9 | 6.5 | 1.4 | 77.7 | 41.2 |
Cash Taxes Paid | 10.4 | 32.9 | 11.6 | 43.9 | 22.8 |
Cash Interest Paid | 3.3 | 7.5 | 3.6 | 8.2 | 4.2 |
Changes in Working Capital | -42.5 | -68.2 | -13.5 | -88.1 | -30.8 |
Cash From Investing Activities | -408.2 | -78.3 | -49.8 | -136.1 | -116.2 |
Capital Expenditures | -13.6 | -77.6 | -49.5 | -134.8 | -116.1 |
Other Investing Cash Flow Items, Total | -394.6 | -0.7 | -0.3 | -1.3 | -0.1 |
Cash From Financing Activities | 321.4 | -46.1 | -32 | -55.1 | -27.1 |
Financing Cash Flow Items | 0 | 0 | |||
Total Cash Dividends Paid | -37.4 | -44.8 | -31.8 | -37.9 | -25.9 |
Issuance (Retirement) of Stock, Net | 180.8 | 2.3 | 1.7 | 2.3 | 1.3 |
Issuance (Retirement) of Debt, Net | 178 | -3.6 | -1.9 | -19.5 | -2.5 |
Foreign Exchange Effects | 2.3 | 4 | -1 | -6.9 | -3.2 |
Net Change in Cash | -33 | 2.5 | 5.3 | -109 | -88.4 |
投資者名稱 | 投資者類型 | 流通股百分比 | 持有股份 | 股份變動 | 持有日期 | 換手率 |
---|---|---|---|---|---|---|
BNP Paribas Asset Management France SAS | Investment Advisor/Hedge Fund | 6.7582 | 7697132 | 116493 | 2023-10-26 | LOW |
Barclays Wealth | Investment Advisor/Hedge Fund | 6.5827 | 7497298 | 475778 | 2023-10-26 | MED |
BlackRock Investment Management (UK) Ltd. | Investment Advisor/Hedge Fund | 5.7701 | 6571802 | -303696 | 2023-10-27 | LOW |
Société Générale Securities Services S.A. | Research Firm | 4.9038 | 5585132 | -429889 | 2023-10-27 | LOW |
Ostrum Asset Management | Investment Advisor | 4.8093 | 5477494 | 13148 | 2023-10-27 | MED |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 4.4274 | 5042517 | 23611 | 2023-10-26 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 3.4318 | 3908560 | -20999 | 2023-09-14 | LOW |
NBC Global Finance, Ltd. | Corporation | 3.0452 | 3468246 | -1137336 | 2023-10-26 | MED |
Bank of Nova Scotia | Bank and Trust | 3.0262 | 3446604 | 1123723 | 2023-10-27 | MED |
Brown Capital Management, LLC | Investment Advisor | 2.8876 | 3288786 | -196740 | 2023-10-20 | LOW |
UBS Limited | Research Firm | 2.4145 | 2750008 | 1619452 | 2023-10-26 | HIGH |
J.P. Morgan Securities plc | Research Firm | 2.3944 | 2727124 | -1236978 | 2023-09-25 | MED |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.7406 | 1982380 | 1989 | 2023-10-01 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 1.7196 | 1958552 | -35687 | 2023-10-27 | LOW |
Jefferies GmbH | Hedge Fund | 1.4955 | 1703250 | 328929 | 2023-07-21 | LOW |
Rathbone Unit Trust Management Limited | Investment Advisor/Hedge Fund | 1.3067 | 1488270 | -305406 | 2023-10-27 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.1204 | 1276082 | -12 | 2023-10-26 | LOW |
Baron Capital Management, Inc. | Investment Advisor/Hedge Fund | 1.1172 | 1272410 | -120000 | 2023-08-18 | LOW |
Nuveen LLC | Pension Fund | 1.0909 | 1242443 | -83027 | 2023-08-17 | LOW |
Goldman Sachs International | Research Firm | 1.0499 | 1195823 | 1195823 | 2023-06-09 | MED |
差價合約交易計算器
如果您在特定日期(選取一個日期)開立差價合約交易並在不同日期(選取一個日期)關閉交易,計算您的假設盈虧。
交易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
打開
關閉
做空 做多
Dechra Pharmaceuticals Company profile
关于 Dechra Pharmaceuticals PLC
Dechra Pharmaceuticals PLC从事兽药及相关产品业务。 该公司从事兽医产品的开发、生产和销售。 它的分部包括欧洲制药、北美(NA)制药和制药研究与开发。 欧洲制药部门包括Dechra兽医产品欧洲公司、Dechra兽医产品国际公司和Dechra药品制造公司。 它制造和销售伴侣动物、马匹、食品生产动物产品和营养品。 北美(NA)制药分部包括Dechra Veterinary Products US、Dechra Produtas Veterinarios(墨西哥)和Dechra Veterinary Products Canada,销售伴侣动物、马类和食品生产动物产品。 该部门还包括其位于佛罗里达州墨尔本和德克萨斯州沃斯堡的生产单位。
Industry: | Veterinary Drugs |
24 Cheshire Avenue
Cheshire Business Park
NORTHWICH
CHESHIRE CW9 7UA
GB
收入報表
- Annual
- Quarterly
人們也觀看
还在找一位您可以信任的经纪商吗?
加入成为全球570,000万多名交易者的一份子,选择利用Capital.com进行交易吧。